{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T20:47:23Z","timestamp":1774385243969,"version":"3.50.1"},"reference-count":28,"publisher":"SLACK, Inc.","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pediatr Ophthalmol Strabismus"],"published-print":{"date-parts":[[2014,11]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To compare clinical practice patterns regarding atropine penalization use by UK orthoptists to the current evidence base and identify any existing barriers against use of AP as first-line treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>An online survey was designed to assess current practice patterns of UK orthoptists using atropine penalization. They were asked to identify issues limiting their use of atropine penalization and give opinions on its effectiveness compared to occlusion. Descriptive statistics and content analysis were applied to the results.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Responses were obtained from 151 orthoptists throughout the United Kingdom. The main perceived barriers to use of atropine penalization were inability to prescribe atropine and supply difficulties. However, respondents also did not consider atropine penalization as effective as occlusion in treating amblyopia, contrary to recent research findings. Patient selection criteria and treatment administration largely follow current evidence. More orthoptists use atropine penalization as first-line treatment than previously reported.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Practitioners tend to closely follow the current evidence base when using atropine penalization, but reluctance in offering it as first-line treatment or providing a choice for parents between occlusion and atropine still remains. This may result from concerns regarding atropine\u2019s general efficacy, side effects, and risk of reverse amblyopia. Alternatively, as demonstrated in other areas of medicine, it may reflect the inherent delay of research findings translating to clinical practice changes.<\/jats:p>\n            <jats:p>\n              <jats:bold>[J Pediatr Ophthalmol Strabismus 2014;51(6):363\u2013369.]<\/jats:bold>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.3928\/01913913-20141021-08","type":"journal-article","created":{"date-parts":[[2014,11,26]],"date-time":"2014-11-26T20:51:12Z","timestamp":1417035072000},"page":"363-369","source":"Crossref","is-referenced-by-count":4,"title":["Use of Atropine Penalization to Treat Amblyopia in UK Orthoptic Practice"],"prefix":"10.3928","volume":"51","author":[{"given":"Marianne","family":"Piano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna R.","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Newsham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2308","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.81.1.54"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2007.10.029"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2008.03.006"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.120.3.268"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.22599\/bioj.20"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(97)30048-7"},{"key":"e_1_3_2_8_2","volume-title":"Presented at the 10th International Orthoptic Congress - Global Perspectives Converge Down Under","author":"McNamara R","unstructured":"McNamara R, Rice T. Atropine occlusion: how long does it take? Presented at the 10th International Orthoptic Congress - Global Perspectives Converge Down Under; November 14\u201317, 2004; Melbourne, Australia."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2009.03.002"},{"key":"e_1_3_2_10_2","first-page":"1634","article-title":"Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial","volume":"126","author":"Scheiman MM","year":"2009","unstructured":"Scheiman MM, Hertle RW, Kraker RT, et al. Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial. Arch Ophthalmol. 2009;126:1634\u20131642.","journal-title":"Arch Ophthalmol"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2009.172015"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.87.3.291"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(39)80097-X"},{"key":"e_1_3_2_14_2","first-page":"25","article-title":"Reverse amblyopia with atropine treatment","volume":"24","author":"Hainline BC","year":"2009","unstructured":"Hainline BC, Sprunger DC, Plager DA, Neely DE, Guess MG. Reverse amblyopia with atropine treatment. Binocul Vis Strabismus Q. 2009;24:25\u201331.","journal-title":"Binocul Vis Strabismus Q"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.4103\/0974-620X.71897"},{"key":"e_1_3_2_16_2","first-page":"1","article-title":"Editorial: implementation of research findings in the clinic","volume":"8","author":"Stewart CE","year":"2011","unstructured":"Stewart CE. Editorial: implementation of research findings in the clinic. Br Ir Orthopt J. 2011;8:1\u20132.","journal-title":"Br Ir Orthopt J"},{"key":"e_1_3_2_17_2","article-title":"Atropine treatment for amblyopia ex anopsia","volume":"22","author":"Lowe RF","year":"1965","unstructured":"Lowe RF. Atropine treatment for amblyopia ex anopsia. Br Orthopt J. 1965;22.","journal-title":"Br Orthopt J"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1067\/mpa.2002.127920"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2008.520"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.04.032"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.22599\/bioj.52"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2004.07.007"},{"key":"e_1_3_2_23_2","volume-title":"Annual Report and Statement of Accounts 2011","author":"British and Irish Orthoptic Society","year":"2011","unstructured":"British and Irish Orthoptic Society. Annual Report and Statement of Accounts 2011. London: British and Irish Orthoptic Society; 2011."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.3368\/aoj.57.1.60"},{"key":"e_1_3_2_25_2","volume-title":"Diagnosis and Management of Ocular Motility Disorders","author":"Ansons A","year":"2005","unstructured":"Ansons A, Davis H. Diagnosis and Management of Ocular Motility Disorders. Oxford: Blackwell; 2005."},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.84.6.572"},{"key":"e_1_3_2_27_2","volume-title":"Duane\u2019s Foundations of Clinical Ophthalmology","author":"Apt L","year":"2006","unstructured":"Apt L, Gaffney WL. Adverse effects of topical eye medication in infants and children. In: , Tasman WMD, ed. Duane\u2019s Foundations of Clinical Ophthalmology. Philadelphia: Lippincott, Williams & Wilkins; 2006."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.22599\/bioj.35"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.09.019"}],"container-title":["Journal of Pediatric Ophthalmology &amp; Strabismus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.healio.com\/doiresolver?doi=10.3928\/01913913-20141021-08","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T17:53:03Z","timestamp":1683568383000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/01913913-20141021-08"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["10.3928\/01913913-20141021-08"],"URL":"https:\/\/doi.org\/10.3928\/01913913-20141021-08","relation":{},"ISSN":["0191-3913","1938-2405"],"issn-type":[{"value":"0191-3913","type":"print"},{"value":"1938-2405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}